Special report: How cannabis could shape future autism therapies

Recent articles

Brain and marijuana leaves
Spectrum Microphone

Q&A with Eric Hollander: Cannabis treatments for autism

As cannabis prohibition slowly lifts in the United States, scientists and families in the autism community are increasingly turning to the drug and its constituent compounds to ease autism-related difficulties, including seizures and irritability.

By Peter Hess
8 June 2021 | 6 min read
Illustration of a neuron on top of a marijuana leaf surrounded by psychadelic colors.
Spectrum Microphone

Cannabis and autism, explained

Autistic people and their families are increasingly experimenting with marijuana to try to ease problems such as insomnia, epilepsy and chronic pain — and traits of autism. But there is little evidence for its safety or effectiveness.

By Peter Hess
7 September 2020 | 8 min read
Woman rolling a marijuana joint.
Spectrum Microphone

Researchers urge caution over study linking marijuana to autism

Women who use marijuana while pregnant may be more likely to give birth to an autistic child. But investigators call for a cautious interpretation of the results.

By Laura Dattaro
18 August 2020 | 5 min read
Marijuana plant

Cannabis compound improves sociability in autism mouse model

A single dose of cannabidiol, a component of marijuana, eases seizures and improves learning and sociability in mice with mutations in an autism gene called CDKL5.

By Bahar Gholipour
22 October 2019 | 2 min read
Photograph of marijuana plant in dark setting.

Drug agency ruling on marijuana may do little to ease autism research

The U.S. Drug Enforcement Agency has made it legal for doctors to prescribe an epilepsy drug derived from marijuana. But all other compounds derived from marijuana remain under tight restrictions.

By Jessica Wright
1 October 2018 | 3 min read
Gate keepers with long documents and spears in front of fortress full of marijuana leaves.
Spectrum Microphone

Federal chokehold on marijuana stymies studies on epilepsy, autism

Scientists' desire for evidence-based medical inquiry runs headlong into an apparently immovable obstacle: the U.S. Drug Enforcement Agency.

By Shaun Hussain
11 September 2018 | 8 min read
Collage illustration shows sun rising behind medicine dropper with marijuana leaves growing out of it.

Drug approval could boost research on marijuana treatment for autism

The United States has approved a compound derived from marijuana as a treatment for certain types of epilepsy. The ruling may spell good news for autism research.

By Jessica Wright
16 August 2018 | 5 min read

Marijuana ingredient sparks social behavior in epilepsy model

Cannabidiol alleviates seizures and restores social ability in a mouse model of Dravet syndrome by soothing overexcitement in the brain.

By Ann Griswold
15 November 2016 | 3 min read
Image of pots and pans hanging from the ceiling. This is meant to be a visual pun, because marijuana is also known as 'pot'.

The pioneers: How parents are experimenting with marijuana for autism

Meet the backyard marijuana growers and home chemists who are rushing in where scientists fear to tread.

By Jessica Wright
14 September 2016 | 20 min read

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read